Concepedia

Muamera Zulcic

MZ

6

Publications

388

Citations

6

H-Index

2014

Active since

Affiliations

University of California San Diego(Current)

Rady Children's Hospital-San Diego

SignalRx Pharmaceuticals (United States)

University of San Diego

Muamera Zulcic is an author at University of California San Diego specializing in medicine, cell biology, and cell development.

Top concepts

Publications per year

2014–2020

6

Publications

6

A Macrophage-Dominant PI3K Isoform Controls Hypoxia-Induced HIF1α and HIF2α Stability and Tumor Growth, Angiogenesis, and Metastasis

Shweta Joshi, Alok R. Singh, Muamera Zulcic et al. · Molecular Cancer Research · 2014 · 123 citations

Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo

Shweta Joshi, Alok R. Singh, Muamera Zulcic et al. · PLoS ONE · 2014 · 122 citations · Full text

, , +17

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer

Shweta Joshi, Alok R. Singh, Kevin X. Liu et al. · Molecular Cancer Therapeutics · 2019 · 46 citations · Full text

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype

Shweta Joshi, Alok R. Singh, Simon S. Wong et al. · PLoS ONE · 2017 · 33 citations · Full text

, , +22

Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression

Shweta Joshi, Kevin X. Liu, Muamera Zulcic et al. · Molecular Cancer Therapeutics · 2020 · 33 citations · Full text

Rows per page

1–5 of 6